Diabetes insipidus (DI) is a rare medical condition that disrupts the body's ability to regulate water, resulting in excessive thirst and an unusually high volume of urine. This condition affects the kidneys' ability to concentrate urine and causes individuals to produce between 3 and 20 quarts of dilute, colourless urine daily, compared to an average of 1 to 2 quarts. It is pertinent to note that DI is not related to diabetes mellitus, which disrupts the body's insulin production.

Types Of Diabetes Insipidus

This condition results from damage to the hypothalamus or pituitary gland, which impairs the production or release of vasopressin, a hormone responsible for water retention. When vasopressin levels are inadequate, the kidneys fail to conserve water, leading to excessive urination. It can result from Brain injuries or surgeries, tumours, infections or inflammation and aneurysms.

Nephrogenic Diabetes Insipidus

This type occurs when the kidneys fail to respond to vasopressin, causing excessive fluid loss. Common triggers include chronic kidney disease, and electrolyte imbalances, such as high calcium or low potassium levels. Additionally, medications like lithium

and urinary tract blockages can also cause Nephrogenic DI.

Gestational Diabetes Insipidus

A rare condition seen only during pregnancy, this occurs when the placenta produces an enzyme that breaks down vasopressin or increases prostaglandin levels, reducing kidney sensitivity to the hormone. Symptoms of this are usually mild and often resolve postpartum but can recur in future pregnancies.

Symptoms And Warning Signs

• Severe thirst, often leading to the consumption of over a gallon of water daily
• Frequent urination (polyuria), sometimes exceeding 20 quarts per day
• Nighttime urination and bed-wetting
• Weakness, muscle pain, and preference for cold drinks

In severe cases, dehydration may develop, manifesting as fatigue, dizziness, dry mouth, confusion, nausea, or fainting. Infants and children with DI may exhibit crankiness, poor feeding, slow growth, fever, or vomiting.

Causes And Risk Factors

DI stems from issues with vasopressin production or response. Central DI arises from damage to brain structures, while nephrogenic DI relates to kidney dysfunction. Risk factors include:

- Genetic mutations affecting water regulation

- Certain medications like diuretics or lithium

- Metabolic disorders that alter calcium or potassium levels

- Brain injuries or surgeries

Diagnosis And Testing

Diagnosing DI involves a combination of medical history, physical exams, and specialized tests:

- Urinalysis: Evaluates urine concentration and glucose levels to distinguish DI from diabetes mellitus.

- Blood tests: Check electrolyte, glucose, and vasopressin levels.

- Water deprivation test: Measures changes in weight, blood sodium, and urine concentration during fluid restriction.

- MRI: Detects abnormalities in the hypothalamus or pituitary gland.

- Genetic screening: Identifies inherited risk factors.

Although DI is rare, affecting about 1 in 25,000 people, early diagnosis and targeted treatment can significantly improve quality of life. Researchers continue to explore its causes and treatments to better support those living with this challenging condition.

Actress Lisa Ray was diagnosed with Multiple Myeloma, an incurable but treatable blood cancer, in 2009. She successfully went into remission but experienced a cancer relapse shortly after her wedding in 2012.

During her journey to recovery, she became a prominent advocate for cancer awareness and research. However, it was during this period, at the age of 37, that she also suffered chemo-induced menopause — a topic she brushed aside, not wanting to bring it up out of shame and fear, reflecting the taboo society still associates with the natural end of a woman’s reproductive phase.

In an interaction with HealthandMe, the Oscar-nominated film Water (2005) actress opened up about her experience with chemo-induced menopause.

“I went into chemo-induced menopause at 37. I was given no support. I was completely lost. And even for a subsequent decade after that, I couldn’t find any answers. I didn’t know how to take care of myself. I didn’t know I had options,” she said.

‘I Carried This Burning Secret Inside Me’

The actress shared that she normalized many of her symptoms and avoided speaking openly about menopause despite being candid about cancer.

“I was so vocal about cancer. I’m actually somebody who prefers to be quite truthful about what I’m going through. I don’t really like to hide things. I’m not secretive by nature. And yet, I carried this burning secret inside me for so many years,” she said.

“When I was being lauded as someone who was breaking through the silence of cancer, I was carrying the silent secret inside me. I couldn’t understand why for many years. And I realized today, I was carrying shame.”

She noted that menopause continues to remain a deeply misunderstood and under-discussed subject, despite affecting all women.

‘Menopause Was Like A Black Box’

Lisa said conversations around menopause were absent even within families.

“My mother never talked to me about menopause. Of course, we discussed my period when I got it, but menopause was simply like a black box,” she said.

The actress recalled that discussions around perimenopause and menopause only began when many of her close friends started experiencing symptoms themselves.

Calling the silence around menopause “astonishing” and “extremely unjust,” Lisa said women’s hormonal health continues to be severely underfunded and misunderstood globally.

“Menopause impacts all women. Yet it’s treated like a dark secret,” she told HealthandMe.

Lisa added that once she began researching the issue, she became increasingly frustrated by the lack of awareness and medical attention surrounding menopause and hormonal health.

Menopause Not Getting Enough Attention

The actress said that after moving to Dubai, she began openly discussing menopause on social media, despite initially worrying about public reaction.

“Sometimes in social settings, women would almost shut down or turn away and say, ‘Don’t talk about that.’ But when I put it on social media, maybe it permitted a lot of other women to also find a place to have a conversation or a community,” she said.

To bring about change where women can speak freely about the topic and seek treatment early, Lisa has co-founded NuHer, a science-backed health clinic and platform dedicated to midlife care for women. It is designed to support perimenopause and menopause through personalized medical treatments, clinical psychology, and nutritional guidance.

When asked why she chose to focus on menopause and women’s hormonal health, the Four More Shots Please! actress stated, “Menopause is simply not getting the attention that it needs. Women are struggling to get the care that they need and understand their options.”

Lisa explained that while awareness around cancer has steadily improved in India since her multiple myeloma diagnosis in 2009, menopause remains “the next taboo or frontier.”

According to Lisa, NuHer aims to create a safe, science-backed space where women can access support without judgment or dismissal.

“We need a place where women can be heard, where they’re not dismissed, where they’re not gaslit, where they receive all the right science and the options they can choose for this journey,” she told HealthandMe.

She also criticized the tendency to dismiss menopausal symptoms as a “normal” part of aging without offering support or treatment options.

“Women are not broken. Menopause is not a disease like cancer that has to be cured. But women need support. We don’t need to normalize suffering,” Lisa said.

Menopause Is 'Stepping Into Our Power Age’

Speaking about aging and post-menopause life, Lisa argued that society often dismisses older women despite what she described as a biologically important phase of life.

“We’ve had terrible PR as aging women. We are dismissed and considered irrelevant when actually we’re stepping into our power age if we know how to take care of ourselves,” the acclaimed actress told HealthandMe.

However, the problem arises when menopause is left unaddressed, and the hormonal changes cause long-term health impacts, including bone health, heart disease risk, and possibly dementia.

“The problem is with the drop in hormones. If you don’t have strategies and lifestyle changes to support yourself post-menopause, you become a frail woman. Your bones suffer. You’re more prone to heart disease and possibly even dementia,” she said, urging more women to seek medical help during menopause and not suffer in silence.

GLP-1 agonist drugs like Ozempic, Mounjaro, and Wegovy, may not only help treat obesity and diabetes but also improve survival among breast cancer patients, according to a new study.

The research published in JAMA Network Open suggests that the GLP-1 agonist drugs can lower deaths in breast cancer patients as well as cut down the risk of recurrence of the deadly cancer.

Breast cancer patients who used GLP-1 RA had an overall lower risk of death from any cause over a 10-year follow-up period.

Similarly, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.

"This study suggests that GLP-1 drugs may offer protective benefits, potentially improving survival and recurrence risk in some female patients with breast cancer—whether this is related to weight control, improved cardiovascular health, or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Chair in Cancer Research at Virginia Commonwealth University’s Massey Comprehensive Cancer Center.

The findings were based on a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023 and also were obese or had type 2 diabetes.

GLP-1 Drugs And Breast Cancer

Also read: World Hypertension Day 2026: Why Switching Salt May Be India’s Simplest Weapon Against High Blood Pressure

Widely hailed as a medical breakthrough, the GLP-1s (glucagon-like peptide-1 receptor agonists) act like the gut hormones that regulate appetite and blood sugar.

It acts specifically on obesity and diabetes — well-established risk factors that significantly elevate the risk of breast cancer progression and recurrence.

GLP-1 medications help lower the risk of breast cancer by promoting weight loss and decreasing circulating tumor activity. It also lowers blood sugar.

Studies have showed that people taking GLP-1s also experience fewer chemo side effects. They were less likely to have anemia, blood clots in veins, low levels of white blood cells called neutrophils, low blood platelet count, sepsis, nausea and vomiting, fatigue, cardiomyopathy, and neuropathy after chemotherapy.

However, the Virginia Commonwealth University study researchers noted that further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes.

Global Burden of Breast Cancer

Read: High Blood Pressure? Daily Soy And Legume Intake May Help Lower The Risk: Study

Breast cancer is the most diagnosed cancer worldwide, accounting for over 2.3 million new cases annually.

According to the WHO's International Agency for Research on Cancer (IARC), it is the leading cause of cancer-related deaths among women, resulting in roughly 670,000 deaths globally each year.

It is also one of the most common cancers among women in the US, and accounts for nearly one-third of all female cancer cases.

The average risk of a woman in the US developing breast cancer sometime in her life is about 13 per cent.

Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.

-Walk into any salon, and you'll be offered a facial for almost every skin concern under the sun. But somewhere along the way, targeted treatments like de-tanning started giving traditional facials a real run for their money. If your main concern is sun damage, uneven tone, or that stubborn dullness that builds up over weeks of stepping out, the de tan vs facial debate is worth having properly.

The perfect de-tan face mask used consistently at home can deliver results that genuinely rival a salon treatment. It helps you in targeting pigmentation and sun damage right at the source without the appointment, the wait, or the cost. What keeps those results going between sessions is just as important. A daily de-tan face wash helps prevent surface tan from quietly rebuilding.

So eventually your skin holds onto its progress rather than starting from scratch every week. Here's a proper breakdown of the difference between de-tan and facial so you can make the right call for your skin.

De Tan Vs Facial for Oily Skin

The core difference comes down to what each treatment is actually designed to do.

De Tan is a targeted treatment built around one primary goal. It aims to dissolve surface-level pigmentation and sun damage. It is made up of chemical exfoliants like AHAs, brightening ingredients like vitamin C or kojic acid, and clay formulas that peel away tanned, dead skin cells to expose younger skin underneath.

A facial is a multi-step ritual that addresses overall skin health, not just one specific condition. It usually comprises cleansing, exfoliating, steaming, extraction, massage, and masks. Each phase has a particular objective. A facial is a great way to boost circulation, tackle a range of skin issues all at once, and give your skin a really good refresh.

Maintaining De-Tan Results at Home: A Wiser Approach

Including a targeted de-tan mask in the weekly regimen can help those who want to keep their skin more even-toned and brighter in between salon visits. Exfoliating acids, oil-balancing clays, and barrier-supporting elements fuel a product that targets dullness, uneven texture, and stubborn tan without stripping the skin.

Products like the Foxtale Skin Radiance De-Tan Mask are particularly helpful for oily, mixed, and sun-exposed skin types since they combine light exfoliation with skin-brightening treatment. Over time, a de-tan treatment at home may make skin seem brighter, fresher, and more radiant when used regularly in conjunction with daily sunscreen.

Which One Suits Your Skin Type?

Oily & Acne-Prone Skin

For oily and acne-prone skin, a targeted de-tan treatment is almost always the safer choice over a traditional facial. Most salon facials designed for brightening use heavy cream-based products, facial massages with oils, and steam, all of which can aggravate acne, clog pores, and trigger fresh breakouts on skin that's already overproducing sebum.

When you use a detan mask with Kaolin Clay and AHAs, it controls excess oil and pigmentation. It does all this without introducing anything that worsens breakouts for you. If you have oily skin, at-home detan treatments done consistently outperform most salon facials in both safety and visible results.

Dry & Dehydrated Skin

A traditional facial that includes a hydrating massage and a nourishing mask can work well here because it addresses moisture levels alongside surface concerns.

That said, a detan treatment isn't off the table for dry skin. The key is picking the right formula, one that uses gentler AHAs like Lactic Acid rather than stronger Glycolic Acid, and that includes hydrating ingredients like Ceramides or Hyaluronic Acid to counterbalance the exfoliation.

Dull & Sun-Damaged Skin

When the skin is suffering from a noticeable tan, uneven tone, and stubborn dullness from sun exposure, a detan treatment is the gold standard of 2026. A facial can provide a glow to your overall tone, but it doesn’t target the melanin deposit that produces your tan and pigmentation. A detan mask with Glycolic Acid, Niacinamide, and brightening clays works on the actual source of the problem, and with consistent use, the results compound over time in a way that a monthly salon facial simply can't replicate.

Which Works Better for Pigmentation and Sun Damage?

Here's a simple way in which you can decide:

Choose a De-Tan when:

• Your main concern is tan, uneven skin tone, or post-sun pigmentation
• You prefer to have targeted, efficient results at home without salon visits
• Your skin is oily or acne-prone and reacts badly to heavy facial products
• You need something you can do consistently every week as part of your routine
• You've just come back from a trip, a wedding season, or an extended time outdoors, and need to reset your skin quickly.

Choose a Facial when:

• Your skin needs an overall reset, not just brightening, but deep cleansing, circulation boost, and hydration together
• You're dealing with multiple concerns at once and want a professional to assess and treat your skin
• Your skin is dry or mature, and benefits from the massage and nourishment steps a facial includes
• You want a one-time intensive treatment before a special occasion rather than an ongoing routine fix.

For most people, the best approach isn't choosing one over the other permanently. In fact, you should understand when each serves your skin best and use them accordingly. A weekly de-tan treatment at home, with an occasional facial when your skin needs a deeper reset, covers most bases without overcomplicating your routine.

Can You Use a De-Tan Mask Instead of a Facial?

The facial vs de-tan debate doesn't have a single winner. It actually depends entirely on what your skin is dealing with and what goal you are trying to achieve. If you have issues with tan, pigmentation, and sun damage, a dedicated detan treatment is a better option for you.

Overall skin health, hydration, and multi-concern maintenance are where a facial earns its place. Know what your skin needs, pick the right tool for the job, and stay consistent; that's where the real results come from.